The Limited Promise of a Malaria Vaccine
After delivering promising results in Phase III trials, a new malaria vaccine, Mosquirix, will enter use in a pilot program in Ghana, Malawi and Kenya in 2018. But shortcomings in the countries' health care sectors could limit the vaccine's efficacy.
(TONY KARUMBA/AFP/Getty Images)
Field tests show the medication's efficacy in about half of those who took it, but the limits of Africa's health care infrastructure could blunt its effect....
TO READ THE FULL ARTICLE
Preview Some FREE Worldview Articles Below:
Copyright © Stratfor Enterprises, LLC. All rights reserved.